PLP2 of Mouse Hepatitis Virus A59 Targets TBK1 to Negatively Regulate Cellular Type I Interferon Signaling Pathway
2011

How a Virus Disables the Immune Response

publication 10 minutes Evidence: moderate

Author Information

Author(s): Wang Gang, Chen Gang, Zheng Dahai, Cheng Genhong, Tang Hong

Primary Institution: Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China

Hypothesis

Can the papain-like protease PLP2 of mouse hepatitis virus A59 inhibit the type I interferon signaling pathway by targeting TBK1?

Conclusion

PLP2 inhibits the type I interferon response by deubiquitinating and inactivating TBK1, preventing IRF3 from activating interferon transcription.

Supporting Evidence

  • PLP2 deubiquitinates TBK1, reducing its activity and inhibiting the interferon response.
  • Overexpression of PLP2 leads to decreased IFN-β promoter activity.
  • PLP2 stabilizes the inactive complex of TBK1 and IRF3, preventing IRF3 from entering the nucleus.

Takeaway

The virus has a special tool that stops our body's defenses from working properly, helping it to spread more easily.

Methodology

The study involved overexpression experiments, co-immunoprecipitation, and luciferase reporter assays to analyze the interactions and effects of PLP2 on TBK1 and IRF3.

Limitations

The study primarily focuses on in vitro experiments, which may not fully replicate in vivo conditions.

Digital Object Identifier (DOI)

10.1371/journal.pone.0017192

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication